Blomgren H
J Clin Lab Immunol. 1980 Jul;4(1):63-8.
Bleomycin (BLM) and Pepleomycin (PEP), two antineoplastic drugs, strongly inhibited PHA-triggered DNA-synthesis of human lymphocytes when present during the culture period. Preincubation of lymphocytes with BLM or PEP for 3 days, however, only reduced the subsequent PHA-stimulations at very high drug concentrations. This differential sensitivity of resting and activated lymphocytes made it possible to inactivate subsets of mitogen or MLC reactive lymphocytes with a high grade of selectivity.
博来霉素(BLM)和平阳霉素(PEP)这两种抗肿瘤药物,在培养期间存在时,能强烈抑制PHA诱导的人淋巴细胞DNA合成。然而,淋巴细胞与BLM或PEP预孵育3天,只有在药物浓度非常高时才会降低随后的PHA刺激。静息淋巴细胞和活化淋巴细胞的这种差异敏感性使得以高度选择性灭活有丝分裂原或混合淋巴细胞培养反应性淋巴细胞亚群成为可能。